National and Kapodistrian University of Athens
Διερεύνηση της ανώμαλης μεθυλίωσης γονιδίων και του στρες του ενδοπλασματικού δικτύου στον καρκίνο του πνεύμονα και μελέτη των μοριακών τους μηχανισμών
Abstract
dc:descriptionThe present study is divided in two parts. In the first part, aberrant promoter methylation was investigated in a set of selected genes involved in early stages of lung cancer. Methylation signature analysis was performed in DNA from sputum of lung cancer patients, using Methylation specific PCR (MS-PCR) and melting curve analysis. However, the low detection rate of methylation in the particular samples led to the study of alternative molecular mechanisms involved in lung carcinogenesis, such as ER stress. ERp29 is an endoplasmic reticulum (ER) luminal protein with a putative secretion factor/escort chaperone function. Accumulated evidence has implicated ERp29 in the thyroglobulin secretion, polyoma virus transport and recently in carcinogenesis. ERp29 levels were elevated in the tumors of various origins and under the conditions of genotoxic stress, such as ionizing radiation. In this study we report the induction of ERp29 during the treatment of lung cancer cells with doxorubicin, a commonly used antineoplastic agent. Experiments in the p53-/- cells and p53 knockout mouse model revealed that doxorubicin effect on ERp29 is p53 dependent. The increase of ERp29 level appears to activate a negative feedback loop where the elevated amounts of ERp29 augment cell viability of cancer cells after doxorubicin treatment as shown by a clonogenic cell survival assay. To elucidate the mechanisms behind the doxorubicin effects we have studied the impact of ERp29 on the interaction with the ER stress-activated eukaryotic translation initiation factor 2-alpha kinase 3 (PERK) that was shown to facilitate tumor cells resistance to drug toxicity. Co-immunoprecipitation demonstrated physical interaction of ERp29 with PERK and moreover overexpression of ERp29 enhanced endogenous levels of PERK. Our results identify ERp29 as a novel regulator of PERK and provide evidence for the role of ER resident factors in the regulation of chemotherapeutic efficacy. These findings show that PERK may represent a nodal point between ER stress and chemotherapeutic response. In the present study, we also investigated if ERp29 and ER stress are involved in non cell-autonomous interaction mechanisms between cancer cells and fibroblasts in the tumor stroma. Our results suggest that pharmacologic induction of ER stress triggered by tunicamycin in cancer cells leads to paracrine stimulation of fibroblasts’ proliferation and that p21 plays a central role in this effect. SenexinA, a small molecule inhibitor of p21 was used for the pharmacologic inhibition of p21-related transcriptional activity, in vitro and in vivo. In the present study we showed that doxorubicin treatment of normal fibroblasts enhances the proliferation of cancer cells, and this mitogenic activity is reduced by pharmacological inhibition of a p21-related function, is detectable in the systemic circulation, persists after the cytotoxic effects of chemotherapy and generates a cellular environment that favors tumor growth.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Farmaki, Eleni
- Φαρμάκη, Ελένη
Subjects
dc:subject × 20- Μεθυλίωση
- Γονίδια
- Στρες του ενδοπλασματικού δικτύου
- Χημειοθεραπεία
- Καρκίνος πνεύμονα
- Μοριακοί μηχανισμοί παθογένειας
- Μοριακοί συνοδοί
- Παρακρινικές δράσης
- Methylation
- Genes
- Endoplasmic reticulum stress
- Chemotheraphy
- Lung cancer
- Molecular mechanisms
- Chaperones
- Paracrine effects
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27363